Triptorelin
Top View
- Clinical Policy: Triptorelin Pamoate (Trelstar, Triptodur) Reference Number: ERX.SPA.45 Effective Date: 07.01.16 Last Review Date: 11.17 Revision Log
- The Role of Gonadotropin-Releasing Hormone (Gnrh) in Endometrial Cancer
- PRODUCT INFORMATION Triptorelin Item No
- Comparison of Oocyte Maturity Rates in Recombinant Human Chorionic Gonadotropin (HCG) and Triptorelin Acetate Triggers: a Prospective Randomized Study
- RX.PA.012.MPC Revision Date: 02/2020 Page Number 1 of 7
- Triptorelin Pamoate (Trelstar) Reference Number: ERX.SPMN.99 Effective Date: 07/16 Revision Log Last Review Date: 06/16
- Role of Gonadotropin-Releasing Hormone (Gnrh) in Ovarian Cancer
- Confidential and Proprietary, © 2018 Unitedhealthcare Services Inc
- The Effects of Cetrorelix and Triptorelin on the Viability and Steroidogenesis of Cultured Human Granulosa Luteinized Cells
- Gonadotropin-Releasing Hormone (Gnrh) Analogues in Prostate Cancer
- Comparison of Assisted Reproductive Technology Cycle Outcomes
- Gonadorelin Analogues for Endometriosis
- Gonadotropin-Releasing Hormone Analogs - Firmagon® (Degarelix for Subcutaneous Injection)
- Therapeutic Class Overview Gonadotropin-Releasing Hormone (Gnrh) Agonists/ Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
- Actions of Gonadotropin-Releasing Hormone Antagonists On
- Triptorelin Pamoate (Trelstar) Reference Number: PA.CP.PHAR.175 Effective Date: 01/18 Last Review Date: 02/17 Revision Log
- Clinical Utility of Elagolix As an Oral Treatment for Women with Uterine Fibroids: a Short Report on the Emerging Efficacy Data
- Gonadorelin Analogues Prescribing Support Information